Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Clinical trial NCT05933278 · COMPLETED
Trial details
- NCT number
- NCT05933278
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2024-08-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.